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Abstract 
 
One of the biggest challenges persons with multiple sclerosis (pwMS) are facing is difficulty 
in walking and this is related to decrease in quality of life (QOL). The throughout day 
variability of walking capacity and everyday unpredictability of symptoms, along with 
perceptions of fatigue may be related to the reduced walking ability and participation in 
functional activity.  
 
Aims and Hypotheses:  
The aims were to analyse the effect of time of day on walking and determine the between-
day retest reliability of the tested 3D gait kinematics analysis and the 10-meter (10mWT) 
walking performance test. This study also aimed to determine the correlation between 
perceived fatigue severity (Fatigue Severity Score, FSS) and the walking performance 
outcome measures; 10mWT and 6MWT.  
 
We hypothesized that there is no effect of time of day on walking. A high test-retest reliability 
(ICC > 0.7) is hypothesized for gait kinematics and the 10mWT. And, the third hypothesis is 
that there is no significant correlation between perceived fatigue and walking performances.  
 
Methodology:  
In this secondary data study, within day differences of gait tested between morning (AM) and 
afternoon (PM) were analysed using paired t-test and Wilcoxon Signed Rank test; while test-
retest reliability of the outcome measures assessed for between-day repeatability was 
evaluated using Intraclass Correlation Coefficient (ICC). The correlation between fatigue 
score and the walking measures were tested with Pearson Correlation Coefficient. 
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Results: 
There is no difference in gait kinematics and walking performance assessed in AM and PM 
sessions. We found moderate to good reliability of gait kinematics and 10mWT as indicated 
by the ICC. Lastly, there is no statistically significant correlation between self-reported 
fatigue and measures of walking capacity. 
 
Conclusion: 
Based on the results, this study suggests that pwMS do not necessarily walk differently in 
the afternoons compared to mornings. The retest reliability offered fulfilment in knowledge 
gap regarding between-day reliability testing. Self-reports of fatigue are less likely to 
associate with objective walking ability suggesting that there may be other influences to 
walking performance in pwMS, and this requires further research. 
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1.0 Introduction  
 
Multiple Sclerosis (MS) is an autoimmune-mediated neurodegenerative disorder of the 
central nervous system (CNS). One in every six hundred people in the United Kingdom has 
MS. This is as estimated by the country’s MS Society (2016) that provides advice, education 
and care for persons with MS (pwMS). The malfunction of immune system in MS destroys 
the protective lining of nerves called the myelin, and the axons of the brain and spinal cord. 
This degeneration, damage and inflammation of the myelin sheath is known as 
demyelination. Lesions or plaques form where the myelin is attacked and in most cases the 
nerve fibres are severed. These then causes the smooth transmission of message signals 
along axons between the brain and body to be blocked or slowed down (NHS 2016).  
 
In human physiology, communication between the brain and the rest of the body is based on 
the proper functioning of the body's sensory and motor capabilities. With MS, sensory and 
motor functions are impaired and disability sets in. This is relatable with Compston and 
Coles (2008) who stated that pathological changes caused become progressive 
accumulation of disability in pwMS. The disease besides being associated with a wide range 
of disability symptoms, is further characterized by exacerbations and remissions in MS 
(Hadjimichael et al. 2008). The vagueness of symptoms and daily fluctuations faced results 
in pwMS having to cope with the varied experiences and challenges of impairments of the 
disease.  
 
One highly rated challenge coping with the disease expressed not only by pwMS but 
clinicians inclusive, is difficulty walking due to feeling fatigue. Assessing walking impairment 
in pwMS is common, and there already exists a considerable amount of studies on this focus 
(Motl et al. 2012; Noguiera et al. 2016). However, these MS studies, without exempt, 
comments on the lack of clear definition of fatigue and the insufficiency of understanding 
how pwMS may experience change in physical partaking throughout a day (Rudroff et al. 
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2018; Dalgas et al. 2018). It is also uncertain from studies if fatigue is significantly related to 
walking capacity. Considering the notably large number of MS persons worldwide, research 
aimed at understanding the influences of time of day and fatigue relationship to walking may 
facilitate development of awareness in rehabilitation and care management.  
 
On another note, a number of outcome measures exists; for instance, the 3-dimensional 
(3D) gait kinematics analysis, 10-meter walk test (10mWT) and 6 minute walk test (6MWT) 
frequently used to measure walking in neurological conditions. These outcome measures 
need to be reliable, in addition to being valid, to express consistency and credibility when 
used as a clinical outcome. Test-retest reliability is one simple way of testing for stability and 
reliability of an outcome measure tested over time. There are evidences in literature of retest 
reliability studies to support the psychometric characteristics of the 10mWT outcome 
measure in populations like spinal cord injury and traumatic brain injury (Scivoletto et al. 
2011; Hirsch et al. 2014), but not for MS specific population. Another drawback also is that 
these reliability testings’ have only been established for within-day or one-week retest 
period. Moreover, there are no studies reporting for the 3D gait analysis outcome in pwMS 
(Andreapoulou et al. 2018). These limitations indicate that reliability studies are rare and 
further studies need to evaluate gait outcome measures statistically specific to pwMS.  
 
This study aimed to contribute to understanding the differences in walking kinematics and 
performance in relation to time of day and to identify the correlation of walking performances 
with perceived fatigue in pwMS. This study also aimed to add to the few available studies on 
test-retest of the 3D gait analysis and 10mWT outcome measures of gait involving the MS 
population. It is hoped that with this understanding, clinicians, carers and individuals with MS 
can act towards management of ambulatory improvements and develop person-centred care 
approaches while not being weighed down by perceived fatigue. This is because walking 
rehabilitation has always been inhibited by concerns of fatigue and the effect of MS on gait. 
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With this study, an evidence-based approach to facilitating rehabilitation for pwMS may be 
furthered.  
 
2.0 Literature review 
2.1 Overview of MS 
Nervous system is the basis by which many body mechanisms are controlled. The nervous 
system is made up of the CNS and the peripheral nervous system. The CNS makes up the 
nerves of the brain and spinal cord. As informed above, these nerve cell fibres are protected 
by myelin sheaths that help ensure a smooth and hastened relay of messages between the 
brain and rest of the body. In MS, the myelin is mistaken as foreign body and is attacked by 
the immune system, causing partial or complete disruption to the function of nerve fibres. It 
is learnt that multiple areas of scarring form at these damaged areas, and hence the 
name multiple sclerosis originated (National MS Society 2018). The affected neural 
pathways in pwMS causes a range of physical and mental functioning difficulties; influencing 
one’s ability to perform meaningful work.  
MS in general is a common disabling neurological condition affecting young adults, and 
hence, causing a high social burden. It is a lifelong chronic disease of unknown etiology, 
with four main clinical phenotypes: clinically isolated syndrome (CIS), characterised by first 
signs of inflammation and demyelination in the CNS; primary-progressive MS (PPMS), 
wherein neurological decline is observed from onset; secondary-progressive MS (SPMS), 
which exhibits greater neurological dysfunction with less or even no relapses, and relapsing-
remitting MS (RRMS), characterised by worsening degeneration and episodes of  remission 
(Multiple Sclerosis Trust 2017, National MS Society 2018). Figure 1 shows an overview of 
the typical disease progresses in MS (Miller 2004). The typical patterns or characteristics 
describe the different courses of the disease and affects pwMS in different ways.  
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Figure 1 Overview of the typical disease progresses in MS (Miller 2004) 
 
An estimated 2.5 million people in the world have MS (Multiple Sclerosis Trust 2017). The 
onset of MS can develop in individuals as young as 2 years old with almost 70% of patients 
manifest symptoms between ages 20 and 40 (National MS Society 2018). Statistics and 
registers inform that there is a clear gender differences; with women being more frequently 
affected than men at a ratio of up to 4:1. Largely, the occurrence of MS increases further 
north or south from the equator but ethnicity may differ this prevalence. Certain ethnic 
groups as the Australian Aborigines and New Zealanders have a markedly lower prevalence 
of developing MS. Scotland, especially northern east of Scotland and Canada has 
particularly high number of MS persons.  
 
There is no cure yet for MS. The life expectancy for pwMS is averaged 7 years lower than 
the general population (Multiple Sclerosis Trust 2017). Nevertheless, this gap appears to be 
getting smaller and quality of life (QOL) of pwMS are being enhanced with improved 
treatment. MS can be a challenging condition to live with as pwMS exhibit a wide variety of 
symptoms from the random distribution of the demyelination lesions in the CNS. Lately, 
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these symptoms are better managed not only at individual level, but also clinically and at 
rehabilitation level. The emphasis in managing MS patients has evidently shifted to multi-
disciplinary teams, with which increased MS based research are crucial for decision making 
in this population.  
 
2.2 Defining disability measures in MS 
 
The Expanded Disability Status Scale (EDSS) is a classification scale widely used in 
assessment of level of MS disability. In clinical context, the EDSS is used to monitor 
progression or changes in the level of disability in pwMS. John Kurtzke in 1983 founded this 
scale which ranged from scoring stages of 0.0-10.0. It is based on a half-point unit increment 
with higher scores representing greater disability (Kurtzke 1983). EDSS of 1.0-4.5 are 
defined by pwMS who are fully independent ambulators; and each precise decimal scoring 
unit is demarcated by Functional Score (FS). The FS is formed of measures of eight 
functional systems including sensory, visual and bowel and bladder function. Grades 5.0 and 
above represent more severe disability with obvious walking difficulties impairing activities of 
daily living (ADL). A representation of the EDSS features is presented in Figure 2 (Multiple 
Sclerosis Trust 2018). The EDSS, although has its flaws as it is denominated by walking or 
mobility and does not capture the impact of MS on individual’s functioning in society, it is 
nevertheless recognized as the ‘gold standard’ or as a primary outcome measure in 
classifying disability.  
 
In relation to understanding MS and limitations to social participation, the World Health 
Assembly in 2001 commended and sanctioned the International Classification of 
Functioning, Disability and Health (ICF) framework in providing a basis for defining health 
and disability (WHO 2018). The framework recognizes that health conditions and their 
effects are altogether the integration of social and medical well-being. According to the ICF 
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framework, co-interaction between health, personal and environmental factors are the 
principals of individual functioning (WHO 2018). Activity and participation describes an 
individual’s functional status and involvement ability which includes taking part in 
commitments, work or social interests. The MS disease which is known to impair body 
function usually results in activity limitation in pwMS, as such described by ICF, affects 
participation willingness. 
 
The ICF is suggested to be applied as an international reference in all aspects of health; be 
it education, providing support services and in clinical practice. The NICE (2014) guidelines 
state that rehabilitation should aim towards promoting self-management and enhance 
functional independence of patients through patient education. Physiotherapy in MS 
rehabilitation are primarily focused on improving mobility problems and fatigue symptoms of 
pwMS by means of exercise provision. Gaining participation for exercise is possibly easier 
when clinicians and pwMS understand the extent of how much fatigue and exercise 
involvement interact in influencing positive exercise experiences. Therefore, research in 
understanding fatigue and gait changes in relation to disability may be of value in 
maximizing potential for rehabilitation care as in this study.  
 
 
Figure 2 Expanded Disability Status Scale (EDSS) (Multiple Sclerosis Trust 2018) 
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2.3 Fatigue symptom in pwMS 
 
Reporting statistics reveal that an average of 50% of pwMS require walking aid and another 
10% become wheelchair dependent following a 15-year MS diagnosis period (Kelleher et al. 
2010). Inopportunely, about 85% of the MS population struggle with gait disturbances in the 
early course of their disease (Bethoux and Bennett 2011). It is most likely also that falls in 
MS are results of postural instability, gait irregularities and muscle weakness which are 
attributable to fatigue. In fact, study results reported that there is significant effect of MS 
fatigue symptom on gait with more than 50% experiencing falls following compromised 
walking ability (Remelius et al. 2012). In relation to this, McLoughlin et al. (2016) adds that 
symptoms of weakness and fatigue commonly alter the normal walking mechanics in pwMS. 
A possible rationale to this may be that alterations in normal walking pattern increases cost 
of energy expenditure required to perform walking, which then seemingly introduces fatigue.  
 
PwMS commonly describe fatigue as a constant sense of weakness causing tiredness which 
is exacerbated usually with activity and as the day progresses (Kayes et al. 2011). Fatigue 
as defined by Kos et al. (2008) is the lack of energy to partake in ADL which can be 
physically or mentally demanding. With scientific explanation set aside, pwMS equated 
feeling fatigue to factors such as personal experiences that are closely related to aspects of 
their lives. This includes employment, relationships, expectations and ability to follow health-
related recommendations (Smith et al. 2013). MS-related fatigue to date has little scientific 
explanation and is difficult to describe nor measure. It takes on the nature of MS by being 
unpredictable and individual to each person. Still studies are required to deliver knowledge, 
establish facts and reach new conclusions about MS-related fatigue. 
 
“‘Really heavy.... I feel as though I have got concrete blocks. That is how I feel all the time’. 
(Donna, Age 52, Relapsing remitting MS)” 
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“‘No, my legs were also not picking up properly, so if I couldn’t walk safely there was no 
point’. (Julie, Age 52, Relapsing remitting MS)” 
 
These expressions of fatigue and fear of falling are as quoted from an interpretive 
descriptive study reported by Kayes et al. (2011, page 633 and 634). The study aimed at 
exploring barriers to ADL participation from the perspectives of pwMS. Only 10 participants 
were involved in this study, but the focused sample selection method provided the study 
findings with information from participants of diversified encounters coping with MS disease. 
This further fulfilled the saturation point criterion of a qualitative study; as enough data was 
gathered and the reported themes answered the proposed research question.  Also, it is 
unclear what the definition of physical activity was in their study, but participants were pre-
informed of this to attain the phenomenon of interest. This impedes the understanding of the 
expanse of physical activity causing expressions of fatigue amongst the participating pwMS. 
Nevertheless, these reported expressions are representative of real life descriptions of how 
fatigue affects pwMS in terms of physical participation; from which meaningful conclusions 
can be communicated.  
 
With regards to physical participation, it cannot be denied that walking constitutes as the 
biggest part and is an important complement for daily living. In other words, walking is the 
main means of locomotion. Unfortunately, pwMS might find themselves troubled by fatigue 
which causes difficulties in walking. This indeed may be one of the first symptoms to be 
noticed in MS (MS Society 2016). PwMS then may start to refrain from undertaking an 
activity or from going out for fear of feeling too tired and not able to complete the amount of 
walking required to fulfil any task. As noted, reasonable amount of studies has been done to 
investigate the effects of this fatigue symptom in MS and to consider the likely detrimental 
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consequences to walking. These studies reported evident alterations in gait, but the extent 
to which fatigue impose on the gait variations however, are vaguely known. 
 
2.4 MS-related fatigue and its association to walking 
 
Fatigue and gait impairments are two of the most disabling and recurring symptoms in 
pwMS. Walking in pwMS is not solely limited by impairments but also by factors as fatigue, 
and so, assessments of gait can be complex. Fatigue is deemed to be multi-factorial and it is 
difficult to ascertain the real cause in order to overcome this symptom. For example, the 
widespread of axon demyelination is usually said to cause fatigue (Steens et al. 2012). 
Likewise, MS related conditions as infection, lack of sleep, pain, and illness can indirectly 
cause fatigue (Andreasen et al. 2011). With the absence of cure for MS, management of 
fatigue symptom is necessary to reduce impact on the person’s lifestyle. The cause of MS 
fatigue, its clinical characteristics, and its relationship to other symptoms, notably gait 
difficulties remain poorly understood based on literature.   
 
There are studies assessing fatigue in MS that found self-reports of fatigue as having 
positive correlation with changes in gait kinematics (Huisinga et al. 2011; Motl et al. 2012). In 
the study of Motl et al. (2012), 44 persons with mild MS completed walking and fatigue 
measures. Findings of their study suggests that gait speed and stride length were 
significantly and inversely associated with energy cost of walking, and that the elevated cost 
of energy in walking is positively associated (p=0.31) with fatigue. Similarly, Huisinga et al. 
(2011) in their study evaluating relationship between fatigue and gait alteration, supported 
the expectation that fatigue is directly proportional to the use of energy in walking. These 
cross-sectional studies however are limited in generalizability as different levels of MS 
disability were not represented and the initial contribution of gait deficit was not accounted 
for.  
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Also, McLoughlin et al. (2016) in their study aimed at analysing induced fatigue in pwMS to 
changes in gait parameters, found gait specific deficiencies of reduced ankle dorsiflexion at 
initial contact phase and increased power use at hip and knee joints. This resulted in feeling 
of exertion, followed with greater self-reports of fatigue. The study had 10 healthy persons 
as comparison, however they did not complement the larger sample size of 34 MS 
participants. Furthermore, the 6MWT was done using a shorter pathway that required larger 
degree of turns instead of the 90° standard test protocol, which may have caused increased 
fatiguability.  
 
As a whole, these studies from Huisinga et al. (2011), Motl et al. (2012) and McLoughlin et 
al. (2016) report that there are significant associations between gait and fatigue, and these 
findings are independent to disability status. It is however recognised that self-reported 
fatigue questionnaires used in such studies posed as limitation to these studies. Therefore, 
this study anticipated that it is ideal to quantify gait outcome measures over time to show 
true reliability or consistency of measures. 
 
2.5 Defining fatigue through rehabilitation 
In rehabilitation, fatigue is seen as a barrier to prescribing exercises and in attaining patients’ 
participation. Studies have assessed for the relationship between improvements of fatigue 
with improvements of walking through rehabilitation. For instance, Sacco et al. (2011) in their 
study had a small sample size of 24 MS participants and 19 healthy control participants to 
analyse gait changes and correlation with fatigue. It was found that gait parameters were 
correlated with fatigue physical score, and improvements in gait parameters were correlated 
with improvement of fatigue. Participants in this study completed 3 weeks of individualised 
multidisciplinary rehabilitation interventions which included aerobics, endurance exercises, 
water or hippo therapy and ADL retraining. These form of rehabilitation exercises however 
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was not focussed solely on gait retraining and may have overall influence to the reported 
findings on gait and fatigue improvements.  
 
Similarly, a systematic review aimed to summarize the effect of exercise on self-reported 
fatigue in MS patients discovered that the likelihood of exercise in reducing MS fatigue is 
positive (Andreasen et al. 2011). Among limitations to note here are the low sample sizes 
and that the reviewed studies measured fatigue as a secondary measure. These may have 
resulted in low statistical power and reduced the likelihood that the results reflected true 
effect. Other supporting evidences and review studies have shown positive effects of 
exercise and rehabilitation on fatigue symptoms (Dalgas et al. 2007), QOL (Motl and Gosney 
2008) and muscle strength (Kjolhede et al. 2012). Khan et al. (2011) as well evaluated from 
published systematic reviews the benefits of rehabilitation; that of which included 
improvement in physical function and participation in pwMS.  
 
There is likewise sufficient evidence on the range of rehabilitative treatments available in 
support of MS symptoms improvement (Dalgas et al. 2007; Rampello et al. 2007). However, 
there is an underrepresentation in the literature of fatigue perception and its effect on 
walking participation. Fatigue is not objectively measurable and deters the purpose of 
estimating for improvements or declines in rehabilitation. This implies that there is a break in 
understanding the optimal frequency, intensity, and the cost-effective form of rehabilitation 
for mobility problems in pwMS. Also, with fatigue being a difficult construct to measure, the 
characteristics of fatigue is questionable and there can be varied unexplainable reasons for 
this symptom in MS.    
 
2.6 Effect of time of day on walking  
It is well reported by pwMS that fatigue levels worsen as time of day progresses. While it is 
expected that fatigue levels affect physical functioning and mobility, the effect of time of day 
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on gait variability and impact on walking has been studied to better interpret for important 
changes. Study findings in general display conclusions that can be contentious to what is 
assumed of pwMS in relation to poorer performance within the day. For instance, Feys et al. 
(2014) assessed for within-day variability in walking in pwMS to identify effects of disability 
and test method (short and long walking tests) on this variation. They found greater changes 
in ambulatory function with short compared to long walking tests when assessed for within-
day variability. They also found that the differences are independent to the MS disability 
when measured at induced fatigue. The results suggest that with habitual walking 
characteristics (long-distance and normal paced), variations in walking from morning to 
afternoon in pwMS are not significantly different.  
 
In another study examining gait and fatigue changes from morning to afternoon in a single 
day, self-rated fatigue increased significantly while gait parameters remained constant 
(Morris et al. 2002). The study specified morning and afternoon measurement times to be 5 
hours apart; and the foot switches of the stride analyser used to analyse gait were not 
removed between trials. The study hereby characteristically attempted to decrease 
variances in measures to reduce error and increase power of the study. Also, missing data 
were addressed, hence there is confidence in drawing inference based from this study. The 
study although relevant to what is believed among pwMS, but the findings are only 
applicable to pwMS with mild to moderate EDSS disability scores. It also reckons that 
ambulation and feeling of fatigue are separate factors, and that objective measures in 
addition to self-reports of fatigue is desirable when considering for changes in pwMS.  
 
2.7 Quantifying fatigue using Fatigue Severity Scale  
 
Despite the impression of decreasing energy level as the day progresses, fatigue is by far 
measured only subjectively via self-reports. There are several self-reporting fatigue outcome 
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measures like the Fatigue Severity Scale (FSS) (Krupp et al. 1989) and Fatigue Impact 
Scale (Fisk et al. 1994) available. These outcomes have been researched in populations of 
MS and have adequate reliability and validity properties as reported in studies (Amtmann et 
al. 2012; Ottonello et al. 2016). The 9-item FSS questionnaire is popularly used and is 
applicable for measuring MS fatigue ranging from physical to mental aspects of daily living. 
Learmonth et al. (2013) carried out a six-month long study period involving 86 MS 
participants to determine the psychometric properties of the FSS. The findings revealed 
good test-retest reliability of the FSS with ICC of 0.75. Other published studies, although not 
individual to the MS population; report FSS having ICC of 0.88 (Valko et al. 2008) and 0.93 
(Whitehead 2009). Thus, the FSS is considered a reliable measure for evaluation of fatigue 
perception as used in this study. 
 
On the other hand, a known limitation to the FSS being a self-reported assessment is that 
the responses can be subjective or have social desirable impact. The lack of objective 
measures to quantify perceived fatigue clearly warrants future exploration. Several 
qualitative studies have been carried out reporting experiences of pwMS in hope to better 
understand feelings of fatigue and the effect towards involvement in ADL. Being reliant only 
on such subjective assessments do not provide for in-depth comprehension of limits of 
fatigue affecting physical role. Majority of MS participants from a study by Kayes et al. 
(2011) that completed a semi-structured interview; concluded that they wished they were 
better informed about the effects and results from being involved in physical activity. They 
also expressed the view that such information, particularly if it came from a credible 
professional, would impart understanding of the related symptoms they are experiencing and 
make them less anxious when getting involved in rehabilitation. It seems that these 
messages or advice are rare in healthcare provision, probably due to the lack of objectivity in 
assessing the significance of fatigue.  
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In a study involving healthcare professionals’ (HCPs) perceptions of challenges and barriers 
of MS fatigue management, fatigue was regarded as a ‘professional challenge’ and ‘stirring 
conflict’ among the interdisciplinary team (Smith et al. 2013). Again, pwMS in this study also 
described disappointment that HCPs exercise prescriptions to them did not match their 
perception or experience of fatigue. Smith et al. (2013) reported that pwMS commonly were 
frustrated that HCPs had difficulties suggesting exercises and advising of their exercise 
limits. In such instances, a more consistent understanding of fatigue experiences and the 
perceptions of pwMS towards physical activity engagement is necessary. This may then 
facilitate better and encouraging exercise experiences for pwMS, improve HCPs choice of 
exercise recommendations to pwMS, as well as sustain confident monitoring of exercise 
progression in rehabilitation. 
 
2.8 Assessment of walking  
 
Gait and walking are terms mostly used interchangeably with no clear distinction in literature 
between these two terms. The primary concept is in the energy used for progression in 
motion. Assessment of gait is normally directed towards identifying any faults or impairments 
in walking. Walking impairment may be life changing and is commonly monitored as an 
indicator of progression of disease and disability. There are various clinical outcome 
measures designed to address walking ability. One of the recommended standardized gait 
assessment is the 3D gait analysis. It is referred to as the benchmark criterion for gait 
assessment to the point of identifying underlying mechanics of gait deterioration or 
alterations (Cameron and Wagner 2011). The psychometric properties of the 3D gait 
analysis although have not been reported specifically for the MS population, accounts for 
high inter- and intra-session reliabilities (Andreopoulou et al. 2017). Besides the 3D gait 
analysis, walking ability typically is measured in clinical MS management with outcome 
measures such as the 10mWT and the 6MWT.  
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The interpretation of changes in gait and walking capacity through objective outcome 
measures requires the knowledge of reliability, validity and responsiveness of the measure. 
The study by Andreopoulou et al. (2017), performed a principal search updated as of May 
2017, to evaluate the psychometric properties of walking outcome measures used for 
assessing walking performance and walking effort in pwMS following use of assistive 
walking technology. Their review identified that there is no evidence available on the 
psychometric properties of 3D gait analysis measured in MS. As for studies assessing the 
10mWT, evaluation of methodological quality revealed fairly good quality of evidences for 
test-retest reliability. While researchers mostly have demonstrated within-day reliability of the 
10mWT, there are almost no studies that have determined the between-day reliability testing 
of the 10mWT and especially in pwMS. The within-day reliability testing alone is considered 
not adequate knowing that pwMS may experience day-to-day fluctuations in performance.  
 
Corresponding to the above, Nilsagard et al. (2007) in their study performed test-retest of 
the 10mWT assessed on three trial measures involving same day testing and at 1 week 
apart. 43 participants were tested and resulted in high ICC with same day testing (ICC=0.92) 
and between-day testing (ICC=0.99). Interestingly, the same high reproducibility of ICC 
(0.97) was reported in Morris et al. (2002) with same day repeated testing of the 10mWT. 
This demonstrates that both within- and between-day variability is established with regards 
to test-retest reliability. Caution must however be taken when interpreting these studies as 
there are limitations of small sample size, the varied disability levels of MS and the 
unavailability of study with longer interim periods that may alter clinical relevance of the 
findings. Considering the complexity of walking task, research on reliability of gait outcome 
measures like the 10mWT must be continuously evaluated to justify for its use as a 
trustworthy clinical assessment tool.  
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2.9 Rationale for this study 
 
PwMS tend to curb their activities because of fatigue and walking limitations. Besides, 
walking impairments added on with the uncertainty of MS symptoms can be equally 
disabling. It remains a query on whether fatigue is just a matter of self-perceived factor 
rather than caused by increased activity. A number of research have considered assessing 
gait outcome measures at several different times of a day to identify for declining changes in 
walking characteristics and performance in pwMS (Fry and Pfalzer 2006; McLoughlin et al. 
2016). More recent studies have featured the use of 3D gait analysis which benefited from 
the perspective of obtaining detailed analysis of changes in gait for pwMS (Huisinga et al. 
2011; Lizama et al. 2016). However, regardless of these available studies, limited 
considerations are directed towards time of day effect on alterations in walking in pwMS. 
Thus, the variability in gait with time of day; differentiating morning and afternoon ambulatory 
performance is regarded a purpose for analysis in this study. 
 
Additionally, with fatigue reported as a barrier to physical participation (Borkoles et al. 2009; 
Stroud et al. 2009) and little known about the day-to-day changes for pwMS experiencing 
this symptom, other means of attaining objectivity in researching this challenge is 
demanded. A suggested approach is to analyse for test-retest reliability so that consistency 
of the findings of outcome measures measured over time is attained. Outcome measures 
like the 10mWT and 6MWT are commonly described in studies, but usually concentrated on 
single day repeated reliability measures. Unlike other outcome measures for gait 
assessment, it is evident also that research has not studied the reliability, validity and 
responsiveness of 3D gait analysis amongst pwMS. Without good between-day retest 
reliability, it is difficult to conclude that the measures are accurate representation of 
performance in pwMS; besides assuming for influences such as environmental, 
psychological or even related to limitations of the testing methodological processes. 
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By way of explanation, it will be advantageous to know whether time of day when outcomes 
of fatigue and gait are being measured or reported, matters. Nonetheless, due to the poorly 
understood multi-factorial nature of fatigue and the unpredictable MS-related functional 
changes, it will also be useful to measure for the test-retest reliability of walking in pwMS. 
Walking ability measured at the same time of day for a few trials over a couple of days would 
serve this purpose; incorporating between day test-retest analysis. This study proceeds with 
the opportunity to analyse the between-day test-retest reliability of the primary results from 
the 3D gait analysis and the 10mWT performance outcome measure. This provides for 
understanding the true retest reliability of these measured outcomes.  
 
Thirdly, the unspecified effect of feeling fatigued to possible changes in walking capacity in 
pwMS, is a problem which is accentuated when relating particularly at rehabilitation 
facilitation. A question of if this pronounced symptom of fatigue has effect in MS and how it 
may associate to walking is raised amongst pwMS, carers and clinicians. In literature, 
prominent studies typically report fatigue using self-assessed questionnaires and are 
assessed along with gait measures. These self-reports of fatigue are however said to be 
limited when implementing for rehabilitation appropriateness as they are subjective in nature 
and may not propose beneficial findings. As studied by Vucic et al. (2010), answers to these 
questionnaires may be influenced by the respondents’ physical, mental and emotional well-
being at that time of reporting. This results in fatigue being a qualitative value and not 
objectively understood.  
 
In monitoring for changes in fatigue levels and walking ability, quite a large part of MS 
research has been dedicated to studying the relationship between fatigue and walking 
(Huisinga et al. 2011; Dalgas et al. 2018). It is interesting that studies found conclusions that 
are varied with respect to the attribute of fatigue outcome measure used. These findings 
found that reports of fatigue assessing physical or mental effort were only weakly correlated 
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to walking capacity, while greater significant correlations were found for fatigue scores 
assessing general health perceptions with response to walking performance. There is still an 
obvious gap in literature regarding the inferences of relationship between fatigue and gait; 
and their usefulness when evaluating pwMS. Therefore, the analysis of correlation between 
FSS and walking performance of pwMS in this study would add to the knowledge of 
ascertaining for any such purposeful relationship.   
 
On the whole, in line with advancement in research and evidence-based practice, this 
secondary study was conducted to establish effects of time of day on functional walking in 
pwMS and to determine the between-day test-retest reliability of walking, given the 3D gait 
analysis and 10mWT data presented in the primary study. This study also reasoned the 
relationship between walking performance and perceived fatigue in pwMS. Understanding 
walking variability, knowledge of reliability in measures and recognising the relationship of 
fatigue limiting participation may well inform research towards maximizing rehabilitation 
potential. Such informed research may arguably result in longstanding adherence and 
improved willingness to perform physical activity then is currently seen lacking among 
pwMS. With better adherence and participation, signiﬁcant improvements in physical, mental 
and social wellbeing is anticipated for pwMS. This study may also facilitate improvement of 
rehabilitation strategy planning, add to the evidence on mobility specific interventions and 
enable development of larger longitudinal studies as such in the MS population.  
 
3.0 Aims and Hypotheses 
 
This secondary data study analysis was done following a primary study by Scott et al. 
(2013). The primary study investigated the effect of Functional Electrical Stimulation on 
walking and incorporated the use of walking-based outcome measures assessed on multiple 
testing occasions. The outcome measures used were the 3D gait analysis, 10mWT and 
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6MWT; in addition to reports of fatigue using the FSS. The primary data on repeated 
assessments of these gait outcome measures and fatigue assessment informs for the 
intentions of this secondary study.  
 
The aims of this current study are: 
1) to determine if there is statistically significant difference between gait kinematics (3D 
gait analysis) and walking performance (10mWT and 6MWT) as assessed in the AM 
and those assessed in the PM  
2) to determine the between day test-retest reliability of the assessment of gait 
kinematics and walking performance assessed at the same time of different days 
3) to assess the correlation between fatigue scoring (FSS) and the walking performance 
tests 
 
The null and research hypothesis for statistical testing are: 1) there is no significant 
differences between the AM and PM assessments of gait kinematics and the 10mWT and 
6MWT walking performance tests (i.e. no effect of time of day on walking in pwMS),  2) there 
is a high test-retest reliability (ICC of 0.7 or more) for gait kinematics and the outcomes of 
10mWT when assessed on the same time of the day (AM or PM) over a period of 3-14 days 
apart, and 3) there is no statistically significant correlation between the FSS, 10mWT and 
the 6MWT accordingly.  
 
4.0 Methodology 
4.1 Methodology of primary study 
The primary study design was a counterbalanced, within-participant, and a repeated 
measure layout with data collected through laboratory assessments at Queen Margaret 
University (QMU), Edinburgh.  In the primary study, MS participants diagnosed by a 
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neurologist, geriatrician, or rehabilitation specialist and fulfilled the inclusion exclusion 
criteria were recruited via a National Health Service (NHS) community physiotherapy service 
in Edinburgh. 
 
The inclusion criteria were those from the age of 18 to 70 years old and referred for 
physiotherapy management. Able to ambulate at least 15 meters on repeated measures with 
or without walking aid was another criterion of inclusion. Exclusion criteria included those 
unable to ambulate the minimal 15-meter required distance, those with visual or neurological 
impairment, those who are pregnant and breast feeding, and those with a recent 
exacerbation or relapse of MS in the past 30 days.  
 
Participants completed the FSS fatigue questionnaire, the 3D gait analysis and the timed 
walking tests at different times of the day over 4 separate visits. The time frame between the 
repeated assessments ranged between 3 days to 2 weeks; a reasonable compromise 
between recollection bias and unwanted clinical change in the participants. The gait 
outcome measures were completed twice for each AM and PM measurements and the time 
of day assessment was counterbalanced per visit. Morning (AM) session ran between 09:30-
11:00 and the afternoon (PM) session was between 13:00-14:30.  
 
Participants first performed the 3D gait analysis which was recorded using the Vicon 3D 
motion analysis system (Vicon Motion Systems, Oxford, UK). A pathway of 7-meter in length 
was walked barefoot and participants completed the same length each for three tested gait 
parameters. The gait parameters were hip range of motion (ROM); left and right, maximum 
ankle plantarflexion (PF) angle; left and right, and stride length during swing phase as 
derived from the 3D gait analysis. Rest was allowed between trials if required. 
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Following the 3D gait analysis, participants completed two trials of the 10mWT and one trial 
of the 6MWT. Participants were timed and instructed to walk a 10-meter measured walkway 
at their preferred pace (Rossier and Wade 2001). As for the 6MWT, participants were asked 
to walk as far as possible within a marked out 16.5-meter elliptical course (Enright 2003). 
The same preferred pace of walking was encouraged and total distance walked in 6 minutes 
was measured. Assistive devices if used were kept consistent and documented from test to 
test.  
 
4.2 Methodology of current study 
The following methodology was applied to articulate this current study’s rationales and aims. 
 
i) Data collection 
Anonymized data from the primary completed study in 2013 was obtained from supervisor. 
These data included de-identified FSS score, the 3D gait analysis measurement and the 
10mWT and 6MWT outcome measure recordings. These were extracted using protected 
databases on a secured network server. The anonymity of data was ensured throughout this 
process by restricting data movement only between supervisor and researcher.  
 
ii) Data analysis 
Descriptive characteristics of participants were established. For statistical presentation and 
best estimation, the average of each two AM and PM measurements were calculated. 
Assessment of normality was tested via Shapiro-Wilks statistical test as the study involved a 
small sample size.  
 
Following the assumption of normality, the effect of time of day (AM vs. PM) was evaluated 
using paired t-test for parametric and a Wilcoxon’s test for non-parametric data obtained.  
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The test-retest reliability of gait outcome measures was assessed using Intraclass 
Correlation Coefficient (ICC (2,1)) and reported based on 95% Confidence Interval (CI). 
Categories used for interpreting ICC are as suggested by Portney & Watkins (2000); ICC 
values of >0.75 represent good reliability, 0.50 – 0.75 represent moderate reliability, and ICC 
values of <0.50 represent poor reliability. To further support findings of test-retest reliability, 
Standard Error of Measurement (SEM) and Minimal Detectable Change (MDC) statistical 
calculations were carried out.  
 
A Pearson Correlation Coefficient was calculated to assess the strength and relationship 
between the FSS, 10mWT and 6MWT. The rule of thumb for interpreting the size of 
correlation coefficient is as cited by Hinkle et al. (2003). The interpretations are; 0.9-1.0 = 
very high correlation, 0.7-0.9 = high correlation, 0.5-0.7 = moderate correlation, 0.3-0.5 = low 
correlation and 0.0-0.3 = no to little correlation, if any. 
 
Statistical significance was accepted at p<0.05 for hypothesis testing analyses. All statistical 
tests were carried out using IBM SPSS Statistics version 23 and missing values in the data 
range were excluded. 
 
      iii) Ethical considerations 
Apart from the original approval obtained in the primary study, this study was reviewed and 
approved by QMU Divisional Ethics panel.  
 
Anonymity of the extracted data in this secondary analysis was maintained using participant 
codes. No data leak was ensured during access and viewing of these data by avoiding scan 
or email of original documentations. Anonymous data collection forms were accessed in 
hard copy obtained from supervisor and data extraction was done via databases that directly 
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stored data to the university’s system server. Final data was stored systematically and 
password secured on QMU’s protected network. 
 
5.0 Results 
5.1 Demographic characteristics of the participants 
Demographic characteristics are reported based on the demographics of participants in the 
primary study. The stated results are given with reference to availability of data at each AM 
and PM session as well as at each assessment day. Although the primary obtained data 
consisted of a greater number of respondents, but for the purpose of this study, only the 
data of 12 participants who completed all the study assessments or fulfilled at least one AM 
and one PM assessment was selected for analysis. The participant characteristics are 
provided in Table 1. There were 3 females and 9 male participants with the total mean age 
of 47.8 years old. EDSS score of the participants were between 2.0 and 4.0; representing 
pwMS of minimal to significant disability but self-sufficient in completing walking with some 
rest.  
 
Table 1    Participant characteristics 
 
Characteristics 
Gender, n 
         Male 
         Female 
 
 
9 
3 
Age, years 
         Mean age 
         S.D. 
 
 
47.8 
6.6 
BMI, kg/m² 
        Mean 
        SD 
 
 
28.3 
3.9 
Walking stick users, n 
 
4 
                                SD = Standard deviation 
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Table 2 Normality statistics for 3D gait analysis, 10mWT and 6MWT 
 
 
 Sig. = Significance probability 
 
 
  z-value Shapiro-Wilk (Sig.) 
lhiprom (°) 
 
AM    
 
 
PM 
 
 
Skewness  -0.469 
Kurtosis     -0.400 
 
Skewness  -0.165 
Kurtosis      0.789 
 
 
-0.736 
 0.325 
 
-0.259 
 0.640 
 
 
0.606 
 
 
0.992 
 
 
rhiprom (°) 
 
AM 
 
 
PM 
 
 
Skewness   0.214 
Kurtosis     -1.634 
 
Skewness  -0.153 
Kurtosis     -0.842 
 
 
 0.336 
-1.326 
 
-0.240 
-0.683 
 
 
0.118 
 
 
0.838 
 
 
lmaxpf (°) 
 
AM 
 
 
PM 
 
 
Skewness   0.198 
Kurtosis       2.367 
 
Skewness   1.514 
Kurtosis       1.917 
 
 
0.311 
1.921 
 
2.377 
1.556 
 
 
0.156 
 
 
0.017 
 
 
rmaxpf (°) 
 
AM 
 
 
PM 
 
 
Skewness    0.190 
Kurtosis       0.239 
 
Skewness    0.439 
Kurtosis       0.171 
 
 
 
0.300 
0.194 
 
0.689 
0.139 
 
 
0.994 
 
 
0.724 
Speed (m/s) 
 
AM 
 
 
PM 
 
 
Skewness    0.127 
Kurtosis      -0.506 
 
Skewness    0.188 
Kurtosis      -1.209 
 
 
 
0.199 
-0.411 
 
0.300 
-0.981 
 
 
0.999 
 
 
0.484 
10mWT (s) 
 
AM 
 
 
PM 
 
 
Skewness    0.907 
Kurtosis      -1.008 
 
Skewness    0.951 
Kurtosis      -0.534 
 
 
1.372 
-0.788 
 
 1.439 
-0.418 
 
 
0.008 
 
 
0.055 
 
 
6MWT (m) 
 
AM 
 
 
PM 
 
 
Skewness   -0.913 
Kurtosis      -0.964 
 
Skewness   -0.992 
Kurtosis      -0.249 
 
 
 
-1.150 
-0.607 
 
-1.250 
-0.157 
 
 
0.078 
 
 
0.236 
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5.2 Test for normality and effect of time of day (AM and PM) on walking 
5.2.1 Normality testing  
The assumption of normality was checked for outcomes of the 3D gait analysis and walking 
performance to determine whether the sample data has been modelled by a normal 
distribution. This assumption also allowed to compute for the use of the t-test statistical 
testing in assessing for the time of day effect on participants walking. The null hypothesis 
used for this normality testing is that the sample data are not significantly different than a 
normal population. Shapiro-Wilk’s test showed that all outcomes, except the lmaxpf (PM 
assessment) gait parameter and the 10mWT (AM assessment), were normally distributed 
(p>0.05). The results for each outcome are presented in Table 2 (refer above).  
 
It is suggested that another formal normality testing is by looking at skewness and kurtosis. 
For small samples sizes of less than 50, the null hypothesis is rejected if the absolute z-
scores for either skewness or kurtosis appears greater than +1.96; with alpha level of 0.05 
(Hae-Young Kim 2013). This is seen with the z-value calculated and reported for lmaxpf 
parameter (skewness=2.377). The 10mWT alternatively displayed z-values 
(skewness=1.372, kurtosis=-0.788) which are significantly different from zero; thereby 
interpreted the non-normal sample distribution. 
 
In addition to that, a visual inspection of the normal Q-Q plot was done to ensure the right 
normality assumption (Loy et al. 2015). The probability plots for the lmaxpf parameter and 
the 10mWT are as presented in Figure 3. From the output, all the plotted points do not fall 
approximately along the normal distribution reference line, hence, normality is not assumed 
for the lmaxpf parameter and the 10mWT. 
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5.2.2 Differences in AM and PM assessment of 3D gait analysis parameters, 10mWT and 
6MWT 
 
The effect of time of day on walking parameters and walking performance was tested by 
paired t-test and Wilcoxon statistical tests accordingly. Since the data for lhiprom, rhiprom, 
rmaxpf and speed followed a normal distribution, the appropriate parametric test for the 
small sample size in this study is the t-test. The lmaxpf and 10mWT data that are not 
normally distributed; a non-parametric Wilcoxon Signed Rank test was performed. As for the 
6MWT, the data set only reported for a very small number of participants (n=7) with 
available paired measurements of the morning and afternoon assessments. The small 
sample size for the 6MWT therefore lacked in sufficient power to provide meaningful results 
on the distribution test and so, a non-parametric Wilcoxon test was performed to compare 
the repeated measurements.  
 
Figure 3 Normal Q-Q plot graphs for lmaxpf (PM) and 10mWT (AM) 
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Table 3 shows the results from the paired t-test analysis whilst Table 4 shows the Wilcoxon 
test results as the non-parametric alternative of the t-test for reporting this association. 
Paired sample t-test conducted for four of the five gait analysis parameters; lhiprom, 
rhiprom, rmaxpf and speed; found that there was no statistically significant difference 
between the scores for AM assessments and PM assessments (p>0.05). This means that 
we fail to reject the null hypothesis; that there is no effect of time of day on gait kinematics. 
There is thus insufficient evidence to prove that pwMS in this study walked any different in 
the morning as compared to in the afternoon.  
 
Table 3 Paired t-test for 3D gait analysis  
 
 Mean t Sig. 95% Confidence Interval 
Lower Upper 
lhiprom (°)   AM 
 
                     PM 
35.95 
 
34.50 
 
 
1.687 
 
0.120 
 
-0.44 
 
3.35 
rhiprom (°)   AM 
 
                    PM 
36.15 
 
35.00 
 
 
1.666 
 
0.124 
 
 
-0.38 
 
2.75 
 
rmaxpf (°)    AM 
 
                     PM 
 
-10.35* 
 
-10.80* 
 
0.355 
 
0.729 
 
 
-2.32 
 
3.21 
speed (m/s) AM 
 
                     PM 
 
0.71 
 
0.69 
 
0.905 
 
0.385 
 
 
-0.03 
 
0.07 
Sig. = Significance probability  
*negative values represent parameters of ankle plantarflexion. 
 
As for the non-parametric Wilcoxon tests (Table 4), the lmaxpf gait parameter (Z=-1.344, 
p=0.182), the 10mWT (Z=-1.956, p=0.050) and the 6MWT (Z=-1.183, p=0.237) indicated 
that AM measurements were not statistically significantly different from the PM 
measurements. Also, there were variations in number of participants with average PM 
measurements lesser than the average AM measurements, however, the differences in 
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measurements were small and failed to result in statistical significance. Here again, we fail 
to reject the null hypothesis; by which there is no effect of time of day on walking 
performance. It is highly probable then that the observed average differences in 
measurements happened by chance.   
 
Table 4 Wilcoxon Signed Rank test  
 
 Mean Rank  Z-value Sig. 
lmaxpf (°)      AM 
 
                      PM 
 
-10.36* 
 
-8.20* 
4/12 participants with 
average PM<average 
AM 
-1.334 0.182 
 
10mWT (s)    AM 
 
                      PM 
12.57 
 
12.96 
 
2/11 participants with 
average PM<average 
AM measurements 
-1.956 0.050 
 
6MWT (m)     AM 
 
                      PM 
 
299.98 
 
293.39 
5/7 participants with 
average PM<average 
AM measurements 
-1.183 0.237 
Sig. = Significance probability 
*negative values represent parameters during plantarflexion. 
 
5.3 Test-retest reliability of the gait analysis and 10mWT 
To inform for test-retest reliability of the 3D gait kinematics analysis and the 10mWT, ICC 
was performed and findings are detailed in Table 5.  
ICC for AM sessions and PM sessions for all assessed parameters of the 3D gait analysis 
and outcomes varied between 0.506-0.970 indicating moderate to good reliability. The 
highest ICC values in both AM (ICC 0.970) and PM (ICC 0.950) assessment was reported 
for the 10mWT indicating the outcome measure has good reproducibility when assessed at 
repeated measures over the between-day test period. 
 
For the 3D gait analysis specific; among all the other parameters, speed exhibited highest 
consistency (ICC 0.931-0.935).  
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Table 5 also included two other statistical values; the SEM and MDC which are used to 
estimate the standard measurement error and smallest amount of change detectable by the 
outcomes beyond the measurement error in the test-retest reliability analysis. SEMs are low 
and MDCs of <10° for gait parameters ROM and <2 seconds for the 10mWT was reported.  
 
Table 5 ICC, MDC and SEM measures for the 3D gait analysis parameters and 10mWT  
 
 ICC 
 
95% Confidence 
Interval 
SEM MDC95 
Lower Upper 
lhiprom (°)   AM 
 
                     PM 
0.672 
 
0.799 
-0.322 
 
0.107 
0.918 
 
0.955 
 
4.33 
 
3.36 
8.48 
 
6.59 
rhiprom (°)   AM 
 
                     PM 
0.892 
 
0.859 
0.567 
 
0.375 
0.973 
 
0.968 
 
2.19 
 
2.02 
4.28 
 
3.96 
lmaxpf (°)     AM 
 
                     PM 
0.687 
 
0.804 
-0.261 
 
0.131 
0.922 
 
0.956 
 
4.26 
 
2.00 
8.35 
 
3.92 
rmaxpf (°)    AM 
 
                     PM 
0.506 
 
0.960 
-0.988 
 
0.823 
0.877 
 
0.991 
 
4.80 
 
1.61 
9.42 
 
3.16 
speed (m/s) AM 
 
                     PM 
0.931 
 
0.935 
0.720 
 
0.712 
0.983 
 
0.985 
 
0.05 
 
0.06 
 
0.10 
 
0.11 
10mWT (s)   AM 
                     PM 
0.970 
0.950 
0.887 
0.780 
0.992 
0.989 
0.91 
0.95 
1.79 
1.86 
ICC = Intraclass Correlation Coefficient, SEM = Standard Error of Measurement, MDC95 = 
Minimal Detectable Change at 95% Confidence Interval 
 
5.4 Correlation between fatigue and walking performance 
The association between fatigue score and walking was assessed using the Pearson 
Correlation test. Table 6 presents the correlation results between the FSS, 10mWT and 
6MWT.  
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Results indicated weak and no statistically significant correlation between FSS and 10mWT 
(r =0.173, p=0.610) and also between FSS and 6MWT (r =-0.138, p=0.745).  
 
However, a statistically significant correlation (p<0.05) was observed between the 10mWT 
and 6MWT with a strong negative correlation, r =-0.910 between these outcome measures. 
This correlational result means that the faster the time taken to complete the 10mWT, the 
lesser the distance walked in the 6MWT or vice versa.   
 
Table 6 Pearson Correlation between FSS, 10mWT and 6MWT 
 Pearson Correlation, r Sig. 
FSS and 10mWT 0.173 0.610 
 
FSS and 6MWT -0.138 0.745 
 
10mWT and 6MWT -0.910 0.002 
 
            Sig. = Significance probability 
 
6.0 Discussion 
This present study analysis, based on a quantitative primary study of gait in MS, aims to 
recreate understanding of the effect of time of day and the between-day reliability of gait 
kinematics and walking performance in pwMS. This secondary analysis study also aims to 
report of the relationship between perceived fatigue and walking performance. The primary 
study is believed to be the only study to have investigated multiple walking tests outcomes 
and performed between-day AM and PM test-retest over a counter-balanced methodology. 
There has been considerable debate regarding gait kinematics and the probable association 
to fatigue in pwMS. The debatable evidences and the prevalence of fatigue in the MS 
population, warranted these aims. In addition, the various fatigue scoring measures 
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available do not evidently explain gait variability, thus, any expression of quantifying this 
possible relationship, are in our interest to investigate.  
 
6.1 Gait kinematics and walking performance in pwMS: differences between morning and 
afternoon 
PwMS are thought to be prone to experiencing increased fatigability as the day progresses 
and as their activities increases (Schwid et al. 2002). It is often a belief that pwMS perform 
or function lesser in the afternoons and when tired. In our study, the measured ROM, speed, 
time and distance showed decreasing values from the AM to PM assessments. For any 
increase that was observed (rmaxpf and 10mWT), the increase was negligible. This may 
allocate the impression that with increasing physical demand or fatigue, walking kinematics 
may be altered. Likewise, in literature, walking kinematics may correspondingly be 
expressive of ambulatory capacity, and thus, we looked at the effect of time of day to gait 
changes in our study. Not many studies have investigated this outlook, whilst relatable 
available studies are repeatedly limited in generalizability by the wide representation of 
EDSS disability, small sample group or insufficient exploration of analysis: i.e. not reporting 
clinical relevance or MDC. 
 
The AM and PM assessments of the 3D gait parameters and walking performance outcome 
measures in our study reported no statistical significant differences. This suggested that 
pwMS did not walk differently in the morning or afternoon, so no effect of time of day on gait 
capability. This finding is in line with a multi-centre study by Feys et al. (2014) who 
investigated 10mWT, 2-minute walk test (2MWT) and 6MWT in a large sample size of 102 
subjects to determine the within-day variability of speed and performance in short (10mWT) 
and long (2MWT and 6MWT) walk tests. The outcomes were tested at 3 specified time 
intervals between morning, noon and afternoon and consisted of fast and usual walking 
pace. Our interest was in the finding from their study that walking assessment at usual 
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speed increased variability with disability level and showed large within day variability, while 
the longer 6MWT showed smaller within-day variability. With regards to time of day, they 
reported that walking variability remained consistent between morning, noon and afternoon. 
Here it proposes that walking capability can be influenced by factors of disability, distance 
walked or ambulatory speed achieved upon walking and not due particularly to the time of 
day. This may be a logical reasoning to the non-significant results in our study.   
 
Few studies have explored for variability of gait assessments by looking into the potential for 
time of day to influence differences in walking patterns. Morris et al. (2002) in their study of 
14 participants and 14 matched control subjects, measured morning to afternoon gait 
consistency with four 10-meter gait trials repeated twice on the same day. The study found 
that MS patients walked slower and showed twice as much variability in gait compared to the 
normal participants. Importantly, the study reports statistical significance of morning and 
afternoon measurements but was recognized to be of non-clinical significance. Their study 
states that despite the perception by pwMS that they are tired or more lethargic in the 
afternoon, no justifiable evidence was found to support for alterations in walking and 
physical performance. Although it is likely that the small sample size in our study failed to 
detect important changes between the tests, but these mentioned studies dispute the belief 
that pwMS perform more poorly in the afternoon than in the morning. With MS having 
considerable impact on gait, knowledge of this time of day differences may be considered an 
important aspect still needing clarification in future MS research. 
 
6.2 Test-retest reliability of 3D gait outcome measures  
 
The test-retest reliability analysis was performed to measure the level of consistency 
between the morning measures and afternoon measures obtained from the between-day 
assessments of the gait outcome measures. The test-retest analysis in our study only 
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involved the 3D gait analysis measures and the 10mWT walking performance test. This is 
probably due to people limitation which resulted in only few participants completing the 
6MWT test. As reported by the 2-way random ICC analysis, moderate to good reliability 
of gait kinematics (ICC 0.50-0.97) and the 10mWT (ICC 0.95-0.97) was found. These 
measure analyses are evident statistically from findings in literature as discussed below.  
 
Referring back to the study by Morris et al. (2002) as referred above, the authors performed 
a repeated measures analyses of variance test (ANOVAs) to analyse gait kinematics, which 
also examined the consistency for walking performance measured in a single day. 
Correlation t-tests was used where ANOVA showed significance to identify the differences 
between groups or across occasions of testing. The results of gait variables were found 
consistent throughout the different assessed time of day. Being the first study to report test-
retest of gait in pwMS, their findings show high degree of repeatability in gait performance 
over the measured intervals. This study is however limited to single day test-retest and 
translated against our study with caution. Besides, there are very few studies reporting for 
between-day test-retest and especially for pwMS, therefore limits further exploration for 
comparisons with our study results.  
 
In a systematic review by Andreapoulou et al. (2018) aimed to identify and synthesize 
literature of psychometric properties for walking performance and lower limb function, 
reports on reliability of the 10mWT was assessed for methodological quality using the 
COSMIN checklist. The review informed of the 10mWT being reliable outcome measure 
owing to the good test-retest values with ICC ranging >0.70. One of the studies mentioned in 
their review is a study by Paltamaa et al. (2008) that presented a test-retest ICC finding of 
0.91 for the 10mWT outcome measure. The study involved 19 subjects with MS and the 
retest interval was one week apart to allow for between-day retest reliability. In a separate 
systematic review by Kieseler and Pozzilli (2012), the 10mWT and a variety of walking 
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performance outcome measures when assessed for reproducibility across pwMS indicated 
that 10mWT is highly reproducible. The walking outcome quantified ICC of 0.81-0.96 within 
the 95% CI and SEM of 0.09 m/s following the analysis of test-retest reliability.  
 
Apart from the 10mWT, the 3D gait analysis was also analysed for test-retest in our study. 
Findings demonstrated moderate to high ICC for this outcome parameters inclusive of hip 
ROM, ankle ROM and speed. In literature, there is lack of studies in the field of MS 
addressing reliability and validity of the 3D gait analysis. The review by Andreapoulou et al 
(2018) also highlighted that the 3D gait analysis used in assessing walking outcomes in 
pwMS, lacked in psychometric evidences. Hence, in our study, assessment of the test-retest 
reliability of gait parameters acquired from the 3D gait analysis hoped to provide as a pilot to 
design larger studies in filling this gap. Secondary to that, the sample size in our study may 
be questioned as too small to provide a real estimate of the reliability testing. Therefore, 
these findings should be interpreted with care and further research on the properties of 3D 
gait analysis is necessary.  
 
Additionally, knowledge of SEM and MDC as in this study forms the basis for interpretation 
of a desirable outcome. The reports of SEM in our study analysis were low for all outcomes 
with the smallest SEM recorded for speed. MDCs based on 95% CI were also reported to 
provide for estimating reliable change in the measures. Our findings indicate reliability and 
precision in the measures obtained; allowing for the interpretation that the 3D gait analysis 
and 10mWT have acceptable random measurement error and good test-retest reliability. 
Although the reporting of SEM and MDC in literature has been encouraged, studies 
reporting these statistical estimates are sparse for gait outcome measures in MS. For that 
reason, our study and the specifics of SEM and MDC may contribute knowledge to this 
existing insufficiency.  
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6.3 Relationship between fatigue and walking performance outcomes  
 
In examining for this relationship, our study found no significant correlation of perceived 
fatigue to the walking outcomes; 10mWT and the 6MWT. Perceived fatigue and its 
association with walking capabilities in pwMS is unclear and this relationship was examined 
recently by Kalron (2016). In his study of 124 MS participants, individuals in the fatigued 
group walked significantly slow with shorter step length and prolonged double support time. 
Fatigue was significantly correlated with 10/14 spatiotemporal parameters of gait, with P-
value from Spearman’s rho correlation highest at 0.99. His study continued to find that the 
strongest correlation of perceived fatigue is with speed (-0.339) and is supported by findings 
of Sacco et al. (2011) and Motl et al. (2012). As gait speed is the measurement outcome for 
walking performance, we estimated that there would be significant correlation between 
fatigue and walking outcome measures. Our study however found no statistical significance 
between fatigue and the gait outcome measures. 
 
In our study, pwMS completed several trials of outcome measures in a day which we 
anticipated the probability of reporting for increased fatigue. We supposed that higher 
energy cost in walking may associate with greater perceived fatigue and trigger walking 
disturbances in pwMS but failed to demonstrate so. A population of pwMS was tested in 
induced fatigue condition by McLoughlin et al. (2016) and found walking induced fatiguability 
affects gait parameters. Findings of the paired t-test from their study showed that pwMS 
experienced a significant increase in exertion level in the last minute of the 6MWT (p<0.01). 
The study methodology used a modified 6MWT and assessed fatigue using a Visual 
Analogue Scale for Fatigue (VAS-F) evaluated pre- and post- to each 6 minute test. This 
study’s methodology of assessing for fatigue represented a better evaluation for correlation 
of fatigue and walking than in our study. As fatigue score was not the main concern in the 
primary study, fatigue was only recorded once throughout the day tests in the study. This 
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single fatigue assessment may not have had a strong effect in representing its correlation 
upon analysis to the 10mWT and 6MWT used.  
 
In favour with Morris et al. (2002), our study findings suggest that changes in fatigue do not 
strongly correlate with changes in walking performance. In available studies, associations 
between self-reported fatigue and reduced walking speed or performance have been noted, 
but, these alterations in walking are more likely to be associated with motor impairments 
than fatigue by itself (Huisinga et al. 2011). An example of this is a study by Kelleher et al. 
(2010) who rationalizes that the power for push off to propel forward in walking is strongly 
determined by ankle PF by which step length and speed is generated. Reduced knee flexor 
and extensor strength and poor balance are other factors limiting gait speed (Yahia et al. 
2011). This is relatable to our study, as lesser active ankle PF and hip ROM may have 
influenced the speed measurements reported from the 3D gait analysis. 
 
Although typical for fatigue to be progressive in nature, Schwid et al. (2002) carries on to 
inform that besides physical activity, fatigue can be triggered by any other factors such as 
pain, illness and sleep quality. Fatigue ratings may also be affected by individual’s 
performance and self-efficacy at the time of reporting. A most recent study by Dalgas et al. 
(2018), which also is the first study to examine the relationship between subjective walking 
ability and MS fatigue impact; marked a progress in deducing new observations pertaining to 
how miscellaneous psychological factors influence perceived walking ability. Their study 
observed that subjective assessments of walking ability showed stronger relationship to self-
reports of fatigue than with objective measures of walking such as the 10mWT and 6MWT. 
These studies and their findings further explain that there is no immediate effect of fatigue 
on walking but may be an indirect resonance of multiple factors. In our study, we were not 
able to gather information on the initial physical activity status or well-being of the 
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participants from the primary study, thus restricted our understanding of other possible 
factors that may well have affected the FSS scoring and the relationship finding.  
 
The same Pearson Correlation results as well showed strong negative correlation between 
the two walking performance tests in our study. This is supported in literature by Dalgas et 
al. (2012) and Kieseier and Pozzilli (2012) that short and long walking tests are strongly 
correlated. These studies referred the short 10mWT to walking effort, therefore, expected to 
be associated with muscle strength; whilst the long 6MWT with walking endurance. White 
(2004) stated that muscle strength deficit in pwMS may result in limited ability to engage in 
physical exercise of sufficient intensity and duration. With this, we assume the significant 
negative correlation found in our study wherein increased fatigue causes reduced walking 
capacity. Similarly, the strength of this correlation can be explained alongside the 
understanding that the 10mWT and 6MWT are outcome measures of comparable 
characteristics. Both outcome measures are used clinically to assess walking capacity and 
also identify improvement or deterioration in walking. Knowing that the 10mWT and 6MWT 
measures elements of physical function, findings of our study can be supported; hence the 
strong correlation.   
 
6.4 Limitations of the study and implications for future research 
There are some limitations to the study, and these include limitations acknowledged from the 
primary study and in this current study. Being a secondary data analysis study, some 
disadvantages and limitations may be existing; such as no control over the primary study 
data and methodology, incomplete available information and may not contain sufficient 
information to testify for the present desired research purpose.  
The most prominent limitation, which has been mentioned above, is the small sample size 
used. It is not clearly known why this limitation was present in the primary study, but, in our 
16007727 
 
38 
 
study, we selected only data of participants with sufficient readings for each outcome trial.  A 
larger sample size would have made the findings from the data much more reliable as it 
would have increased the power of our analyses. Moreover, it would have allowed the 
inferences from the statistical analyses to be more applicable to the MS population. An 
appropriate measure of analysis we specified in our small sample sized study was the SEMs 
which supplemented for meaningful value of significance reporting. Reporting of SEM is 
broadly advocated in research and should be typically informed in future studies. One viable 
way to increase the sample size is to perform a widespread recruitment process which could 
yield more participants. Also, as the study design requires multiple visits to the gait analysis 
laboratory, probably provision of transport or reimbursement for travel fees might deny 
reluctance to travel and facilitate participation. This would however elicit the need for bigger 
research funding and greater time management.  
 
Next is the limitation that the morning and afternoon assessment sessions were not 
adequately divided to represent AM and PM as separate measurements. The span between 
these sessions were not marked and may have affected our findings aimed at demonstrating 
effect of time of day on walking. Ideally, a gap of 6-7 hours separation to distinguish morning 
between afternoon time of day is advised. Therefore, we propose that future studies fix the 
time frames for morning and afternoon sessions, allowing sufficient gap to identify clearly for 
any differences in AM vs. PM walking. There were also no reports of amount of walking or 
physical activity done prior to attending each assessment session, nor records of physical 
fitness documented for each participant. These are amongst the insufficient details detected 
from the primary study data. We only noted from the primary study that rest was permitted if 
needed before and between each trial. The type of MS specific, EDSS specific, level of 
physical fitness and amount of physical activity performed may have underlying influence on  
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measures of walking performance and level of perceived fatigue, and so, needs to be 
informed in detail. The ease with such precision may allow transferability of the study 
findings for potential research.  
 
In terms of study methodology, the sole FSS fatigue score used and assessed once 
throughout the initial study seemed insufficient in representing our study’s correlation 
analysis with walking performance. With fatigue being a variable of interest in our study, we 
were restricted in terms of analysing the true relationship of fatigue and walking capacity. 
The FSS mainly addresses expressions of fatigue in different domains of activity such as 
carrying out duties, work and physical functioning. The outcome also assesses how fatigue 
interferes with social life and affects motivation. With regards to the characteristics of FSS, 
the one-time assessment of fatigue in this study puts the accuracy of participants responses 
into question as it can be reported within the influence of anything at all, and not purely the 
feeling of fatigue following the walking trials. Thus, it is recommended that in future studies, 
an individualised fatigue likert scale before and after each walking assessment be used in 
addition to the FSS. This type of assessment is simple and may provide immediate response 
of feeling fatigue with each assessment trial. On another note, with the understanding that 
self-reported fatigue measures by itself may not identify walking irregularities, it is credible 
that future studies take on the assessment of objective gait measures along with the fatigue 
scales to monitor such changes in pwMS, as implemented in the initial study.  
 
In short, all these steps and suggested opinions should be notably regarded if further studies 
are to be conducted based on the findings of this study.  
 
6.5 Implications to practice 
The fact that most pwMS are diagnosed when they are young adults and are living a longer 
life span resulting from medical management advances, justifies the need for identifying 
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ways to overcome possible limitations of gait affecting ADL participation. As HCPs and 
carers, we acknowledge that it is important for this population to get the best advice and 
treatment regime planned at the appropriate time of day. Such treatment regime should also 
be prescribed confidently to enhance rehabilitation potential and improve compliance to 
physical partaking. This study brought forward some interesting findings which may relate to 
current circumstances especially in rehabilitative management.  
 
Firstly, the finding of this study informed of no distinguishable difference in gait kinematics 
and walking performance of pwMS assessed in AM and PM sessions. This may advise that 
time of day do not alter pwMS walking ability. This is in contrast to their common thinking 
that they are less functional as the day goes by. With further evidences on this topic, 
hopefully pwMS will have a changed perspective on this common belief and build up not 
only physical strength through enhanced rehabilitative measures; but also, mental strength 
to overcome the fear of fatigue symptom. 
 
Next, the findings of good between-day reliability for the gait outcome measures in this study 
is regarded as a start off for future research to address the psychometric properties of 
clinical outcome measures applicable for pwMS. The between-day retest reliability also 
allows for the reporting of clinically meaningful comparisons taking into account possible 
longitudinal changes of pwMS over a longer period of time.  
 
Lastly, the identified poor relationship between self-perceived fatigue and walking 
performance in pwMS suggested that the psychological influences or subjective perceptions 
may not necessarily define the physical capability of pwMS. This finding along with more 
research hoped to recreate an understanding in pwMS to do away with limitations of 
perceptions, which may then substantially support for better physical participation.  
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7.0 Conclusion 
 
In summary, this paper suggested that there is no effect of time of day on walking in pwMS. 
Our results appear to be supported by studies that concluded no justifiable evidence 
supporting differences in gait kinematics and walking capacity assessed in different times of 
day. Nevertheless, we observed from the collected data, a decline in measurements of ROM 
and distance walked in the PM compared to the AM recordings. This finding is valuable in 
light of arguing for what is observed and expressed amongst pwMS in society and in care 
participation. Yet, the limitation of this small size study probably inhibited assumption of 
significant inferences about this prediction that pwMS do no walk differently in the mornings 
as to the afternoons. 
 
This study’s results on test-retest reliability of the 3D gait analysis and the 10mWT informed 
that these outcome measures are reasonably reproducible on repeated measures. The 
10mWT especially is highly reproducible and this conclusion follows from the supporting fact 
that previous studies report high ICCs of the 10mWT in pwMS. As discussed and to our 
knowledge, there are limited studies exploring between-day test-retest analysis of the 
10mWT; and no studies have yet reported reliability of the 3D gait analysis outcome 
measure in pwMS. The psychometric properties of 3D gait analysis need future 
consideration and research in MS. Importantly, these reliability findings add to the 
knowledge gap in research and provides information constructive for larger confirmatory 
studies.  
 
This study continued to measure for possible relationship between self-reported fatigue and 
walking performance. This was done through correlation statistics and found weak 
association with no statistically significant correlation between these measures. It was 
assumed that perceived fatigue levels in pwMS may perhaps affect walking function, but, the 
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findings did not demonstrate for evidence. The limitation of the primary study methodology 
and variation in fatigue symptom may be reasons for this lack of correlation. Nevertheless, a 
strong negative correlation was found between the 10mWT and 6MWT. This strong 
correlation is as supported in literature confirming that these two gait outcome measures are 
significantly associated. This study also interprets the negative correlation between the 
10mWT and 6MWT to be inductive for future researches aim and hypothesis.  
 
The results of this study go some way to comprehend the knowledge of time of day, 
perceived fatigue in pwMS and the relatedness to walking. Future research on these 
outcomes might extend the explanations of the cause and effect of MS on walking capacity 
in the MS population.  
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